Investigation of Treatment‐Related Disparities in Metastatic Pancreatic Cancer Patients Using Real‐World Data
Our findings suggest that there is a modest difference in T2FT by race/ethnicity in the initial time period following diagnosis of mPDAC, but no reported difference in overall survival. Additional studies using a larger, more diverse cohort of patients are recommended to better understand the effects of race/ethnicity on the treatment and survival of patients with mPDAC.
Authors
- Anush Sridharan (ORCID: https://orcid.org/0000-0002-9990-7117)
- Elizabeth A. Handorf (ORCID: https://orcid.org/0000-0003-0445-8978)
- Christina Brown (ORCID: https://orcid.org/0000-0001-8401-5143)
- Kristen A. Sorice (ORCID: https://orcid.org/0000-0002-5501-5782)
- Efrat Dotan (ORCID: https://orcid.org/0000-0002-5762-512X)
- Shannon M. Lynch (ORCID: https://orcid.org/0000-0002-2066-9620)
- Lavanya Aluri
Institutions
- Fox Chase Cancer Center (US)
- Temple University (US)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2025-08-01
- DOI
- https://doi.org/10.1002/cam4.71108
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- U.S. Department of Defense
- American Cancer Society
- Flatiron Health